Patents by Inventor Nilay Patel

Nilay Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150256916
    Abstract: A micro electro mechanical system (MEMS) microphone includes a MEMS device, a flash memory coupled to the MEMS device, and an external port coupled to the flash memory. The external port is configured to be selectively coupled to an external programming device. The external programming device selectively reads first information from the flash memory and writes second information to the flash memory without the use of a one-time fuse.
    Type: Application
    Filed: February 26, 2015
    Publication date: September 10, 2015
    Inventors: Martin Volk, Nilay Patel
  • Patent number: 8633195
    Abstract: This invention offers an effective method of inhibiting the expression of apolipoprotein E by mammalian cells. Apolipoprotein E is a protein that plays a significant role in the development of Alzheimer's Disease in humans. The method comprises administering an effective amount of a triarylmethyl amine compound having the general formula: wherein the R1 group may comprise acyclic amines and aliphatic amines. The R2 group may comprise one of three aryl varieties: aryl, substituted aryl, or heterocycle. Triarylamine compounds inhibit apolipoprotein E expression in mammalian cells. In one aspect of the invention the mammalian cells may be human cells, and more specifically may be human brain cells.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: January 21, 2014
    Assignees: Fresno California State University, Fullerton California State University
    Inventors: Santanu Maitra, Nilay Patel
  • Publication number: 20140005196
    Abstract: This invention offers an effective method of inhibiting the expression of apolipoprotein E by mammalian cells. Apolipoprotein E is a protein that plays a significant role in the development of Alzheimer's Disease in humans. The method comprises administering an effective amount of a triarylmethyl amine compound having the general formula: wherein the R1 group may comprise acyclic amines and aliphatic amines. The R2 group may comprise one of three aryl varieties: aryl, substituted aryl, or heterocycle. Triarylamine compounds inhibit apolipoprotein E expression in mammalian cells. In one aspect of the invention the mammalian cells may be human cells, and more specifically may be human brain cells.
    Type: Application
    Filed: June 28, 2012
    Publication date: January 2, 2014
    Applicants: California State University Fullerton, California State University Fresno
    Inventors: Santanu Maitra, Nilay Patel